VERENIGING HET NL KANKER I has a total of 18 patent applications. Its first patent ever was published in 1999. It filed its patents most often in United Kingdom, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets biotechnology, measurement and pharmaceuticals are ANHUI ANKE BIOTECHNOLOGY GROUP CO LTD, ZOLLO MASSIMO and XINJIANG ACADEMY OF ANIMAL SCIENCES VETERINARY RES INSTITUTE.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 8 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Canada | 3 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | Australia | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Measurement | |
#3 | Pharmaceuticals | |
#4 | Organic fine chemistry | |
#5 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Jacobs Jacqueline | 4 |
#2 | Bernards Rene | 3 |
#3 | Van De Vijver Marc | 3 |
#4 | Van Lohuizen Maarten | 3 |
#5 | Peeper Daniel S | 1 |
#6 | Podust Vladimir | 1 |
#7 | Desmet Christophe J C | 1 |
#8 | Kessels Helmut Wilhelmus Huber | 1 |
#9 | Epping Mirjam | 1 |
#10 | Beijnen Jacob Hendrik | 1 |
Publication | Filing date | Title |
---|---|---|
WO2009116860A1 | Markers providing prognosis of metastasis among cancer patients | |
GB0716591D0 | Composition | |
GB0713192D0 | Anti-tumour methods | |
GB0700281D0 | Methods and Means for the Treatment of Cancer | |
GB0617222D0 | Antibiotics | |
WO2006071843A2 | Biomarkers for breast cancer | |
GB0401876D0 | New use for cancer antigen | |
GB0313625D0 | Therapeutic and assay methods | |
GB0301124D0 | Therapeutic methods | |
EP1297174A2 | Interaction of tbx2 and the arf promoter in cell cycle regulator assays | |
GB0101309D0 | Assay for modulators of the cell cycle |